Walgreens Boots Alliance (WBA)
(Delayed Data from NSDQ)
$9.39 USD
+0.32 (3.53%)
Updated Nov 11, 2024 04:00 PM ET
After-Market: $9.41 +0.02 (0.21%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth D Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$9.39 USD
+0.32 (3.53%)
Updated Nov 11, 2024 04:00 PM ET
After-Market: $9.41 +0.02 (0.21%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth D Momentum A VGM
Zacks News
Walgreens Boots Alliance (WBA) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Walgreens Boots Alliance (WBA) closed the most recent trading day at $26.54, moving +0.38% from the previous trading session.
Walgreens (WBA) and VillageMD Expand Partnership in Chicago
by Zacks Equity Research
Walgreens (WBA) and VillageMD's coordinated primary care and pharmacy services are now available in Chicago.
Zacks Market Edge Highlights: VZ, T, MMM, DIS and WBA
by Zacks Equity Research
VZ, T, MMM, DIS and WBA have been highlighted in this Market Edge article.
Losing Stocks: Buy, Hold, or Sell?
by Tracey Ryniec
Not every stock is at new highs. Several big caps are at decade lows. What should investors do?
Should SPDR S&P Dividend ETF (SDY) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for SDY
Walgreens (WBA) to Advance Diabetes Care at FFL Conference
by Zacks Equity Research
Walgreens (WBA) will sponsor Children with Diabetes' FFL event to make a difference in the lives of the 122 million individuals afflicted by diabetes and pre-diabetes.
Zacks Market Edge Highlights: AI, NVDA, TMUS, V and WBA
by Zacks Equity Research
AI, NVDA, TMUS, V and WBA have been highlighted in this Market Edge article.
How to Avoid the Most Common Investing Mistakes
by Tracey Ryniec
Improve your investing performance through these 3 simple strategies.
Company News for Jun 28, 2023
by Zacks Equity Research
Companies in The News Are: META, WBA, SNOW, NVDA, MANU
Durable Orders Come in Much Higher Than Expected
by Zacks Equity Research
Durable Orders Come in Much Higher Than Expected.
Walgreens Boots' (WBA) Q3 Earnings Miss Estimates, Margins Down
by Zacks Equity Research
Walgreens Boots' (WBA) U.S. Healthcare business expands, owing to key contract wins, continued partnership growth and a strong focus on execution.
Durables, Case-Shiller and Walgreens Mark a Busy Morning
by Mark Vickery
While Durable Goods Orders rose unexpectedly, Case-Shiller home prices fell for the second straight month, and Walgreens Boots Alliance missed on the bottom line.
Here's What Key Metrics Tell Us About Walgreens (WBA) Q3 Earnings
by Zacks Equity Research
While the top- and bottom-line numbers for Walgreens (WBA) give a sense of how the business performed in the quarter ended May 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Walgreens Boots Alliance (WBA) Q3 Earnings Miss Estimates
by Zacks Equity Research
Walgreens (WBA) delivered earnings and revenue surprises of -5.66% and 4.82%, respectively, for the quarter ended May 2023. Do the numbers hold clues to what lies ahead for the stock?
Markets Flat-to-Down to Start a New Trading Week
by Mark Vickery
There were zero major economic reports out this morning, with only Carnival (CCL) posting quarterly earnings.
Walgreens (WBA) to Report Q3 Earnings: What's in the Cards?
by Zacks Equity Research
Continued strategic executions on the United States and the international front is likely to drive Walgreens' (WBA) Q3 revenues.
Is Invesco Dow Jones Industrial Average Dividend ETF (DJD) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for DJD
Zacks Market Edge Highlights: CTAS, GWW, CAT, WBA and IBM
by Zacks Equity Research
CTAS, GWW, CAT, WBA and IBM have been highlighted in this Market Edge article.
Want Passive Income? Try Investing in Stocks
by Tracey Ryniec
Why launch a YouTube channel when you can buy companies that have paid dividends for decades?
Walgreens Boots Alliance (WBA) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Walgreens Boots Alliance (WBA) closed the most recent trading day at $32.39, moving -0.86% from the previous trading session.
Why You Should Retain Walgreens Boots (WBA) Stock for Now
by Zacks Equity Research
Investors are optimistic about Walgreens Boots (WBA) on a strong focus on strategic priorities.
Walgreens Boots Alliance (WBA) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Walgreens (WBA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Walgreens Boots (WBA) Aids Freenome in Early Cancer Detection
by Zacks Equity Research
The collaboration between Walgreens Boots (WBA) and Freenome to advance research based on the early detection of cancer.
ETF Investing Strategies for 2H 2023
by Neena Mishra
We discuss the midyear ETF market outlook and investment ideas.
Walgreens Boots Alliance (WBA) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Walgreens Boots Alliance (WBA) closed at $31.95, marking a +0.98% move from the previous day.